Trial Profile
A retrospective, multicenter study investigating safety and efficacy of combination therapy of sofosbuvir and simeprevir in patients with recurrent Hepatitis C genotype 1 infection post liver transplantation
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 15 Apr 2016
Price :
$35
*
At a glance
- Drugs Simeprevir (Primary) ; Sofosbuvir (Primary)
- Indications Hepatitis C
- Focus Adverse reactions; Therapeutic Use
- 15 Apr 2016 New trial record
- 28 Mar 2016 Results published in the Clinical Transplantation